Status Awaiting development
Technology type Medicine
Decision Awaiting decision
Process Pathways Standard
ID number 6443

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
12 December 2024 Referral
26 July 2024 For information, the company have announced that trial did not meet its primary endpoint and therefore they will no longer be pursuing a Marketing Authorisation Application in this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties as and when the situation changes.
24 November 2023 Awaiting development. Status change linked to Topic Selection Decision being set to Selected
24 November 2023 Topic selection

For further information on our processes and methods, please see our CHTE processes and methods manual